EQS News: Serious incident at Armacell’s Cheonan Armagel plant

On September 7, 2024, the process area of ​​Armacell’s Cheonan Armagel Plant was hit by a fire, followed by an explosion, resulting in significant damage to the assets and a halt in all operations. All necessary emergency protocols were activated immediately.

One of our operators was seriously injured. He received immediate medical attention and is recovering in hospital.

Our priority is to ensure the safety and well-being of our employees, contractors and the local community.

The situation is still being monitored and an investigation team has been established and is on site. Armacell Korea is working with the authorities to determine the cause of this unfortunate event. Safety has always been and will continue to be our top priority.

While Armagel operations have been halted, Armacell Korea’s elastomer plant continues to operate normally.

As soon as more information becomes available, we will keep you updated and we will contact our Armagel customers about the continuation of the supply.

-ends-

About Armacell

As the inventor of flexible foams for equipment insulation and a leading supplier of engineered foams, Armacell develops innovative and safe thermal and mechanical solutions that create sustainable value for its customers. Armacell’s products contribute significantly to global energy efficiency and make a difference around the world every day. With more than 3,300 employees and 25 production sites in 19 countries, the company operates two main businesses, Advanced Insulation and Engineered Foams, and generated net sales of EUR 836 million and an adjusted EBITDA of EUR 155 million in 2023. Armacell focuses on insulation materials for technical equipment, high-performance foams for acoustic and lightweight applications, recycled PET products, next-generation aerogel technology and passive fire protection systems. For more information, please visit: www.armacell.com

Media and investor contacts

Tom Anen

Director Corporate Communications & IR

(email address)